CSIMarket Company Name, Ticker, Customers, else..
 
Silo Pharma Inc  (NASDAQ: SILO)
Other Ticker:  
 
 
Price: $1.9600 $0.09 4.813%
Day's High: $2.02 Week Perf: -1.01 %
Day's Low: $ 1.79 30 Day Perf: 134.76 %
Volume (M): 283 52 Wk High: $ 4.50
Volume (M$): $ 555 52 Wk Avg: $1.44
Open: $1.81 52 Wk Low: $0.77



 Market Capitalization (Millions $) 8
 Shares Outstanding (Millions) 4
 Employees 9
 Revenues (TTM) (Millions $) 0
 Net Income (TTM) (Millions $) -3
 Cash Flow (TTM) (Millions $) 1
 Capital Exp. (TTM) (Millions $) 0

Silo Pharma Inc
Silo Pharma Inc is a pharmaceutical company that focuses on developing psychedelic therapeutics to treat mental health disorders. They aim to explore the potential benefits of psychedelic compounds, such as psilocybin and LSD, in treating conditions like depression, anxiety, and PTSD. The company conducts research and clinical trials to understand the therapeutic effects of these substances on the brain and develop safe and effective treatments. Silo Pharma Inc is committed to bringing innovative solutions to address the unmet medical needs in the field of mental health using psychedelic medicine.


   Company Address: 560 Sylvan Avenue Englewood Cliffs 7632 NJ
   Company Phone Number: 400-9031   Stock Exchange / Ticker: NASDAQ SILO


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
• View Complete Report
   



Contract

Silo Pharma and Sever Pharma Usher in a New Era of Pain Management with Innovative Ketamine Implant Therapy

Published Wed, Aug 14 2024 6:30 PM UTC

In recent developments within the realm of chronic pain management, Silo Pharma, a biopharmaceutical company dedicated to the development of innovative therapeutic solutions, has announced an expansion of its development agreement with Sever Pharma. This collaboration aims to enhance the research and development of SP-26, a groundbreaking dissolvable ketamine-based injectabl...
Stocks on the Move

Silo Pharma Inc. Ventures into Registered Direct Offering, Boosting Future Developments

Published Tue, Jul 23 2024 12:26 PM UTC

In recent news, Silo Pharma Inc. (NASDAQ: SILO), a developmental-stage biopharmaceutical company, has announced its entry into a $2.1 million Registered Direct Offering. This move marks a significant milestone for the company and demonstrates its commitment to advancing novel formulations and drug delivery techniques. The offering will fuel Silo Pharma s endeavors in develop...
Announcement

Silo Pharma Secures $2.1 Million in Funding to Drive Innovative Drug Development

Published Fri, Jul 19 2024 12:01 PM UTC

Silo Pharma Advancing Research and Development with $2.1 Million Registered Direct OfferingSarasota, FL - Silo Pharma, Inc. (Nasdaq: SILO), a prominent biopharmaceutical company specializing in innovative drug delivery systems for traditional therapeutics and psychedelic treatments, is making significant strides in its mission to revolutionize the field of healthcare. The co...
Stocks on the Move

Silo Pharma Inc. Secures Groundbreaking Global License for Alzheimers Drug Development

Published Wed, Jul 17 2024 9:11 PM UTC

Year to date, Silo Pharma Inc. (NASDAQ: SILO) has witnessed a lackluster performance, falling short of the overall market s 18.4% gain. However, recent developments have catapulted the company into the spotlight, as it announces an exclusive global license to develop, manufacture, and commercialize an Alzheimer s drug. This groundbreaking agreement has sparked a surge in Sil...
Licensing Agreement

Silo Pharma Amplifies Intellectual Property Portfolio with Exclusive Global License for Alzheimers Therapeutic

Published Tue, Jul 16 2024 10:30 AM UTC

Silo Pharma Inc., a renowned pharmaceutical company, has recently secured an exclusive global license for a groundbreaking Alzheimer s therapeutic. This agreement is set to significantly bolster the company s intellectual property portfolio while making substantial contributions to the advancement of Alzheimer s research and patient care. Despite the minor downward trend in ...






Silo Pharma Inc's Segments





Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com